These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 34416053)

  • 21. Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine.
    Tuschen K; Bräsen JH; Schmitz J; Vischedyk M; Weidemann A
    Kidney Int; 2021 Oct; 100(4):941-944. PubMed ID: 34352310
    [No Abstract]   [Full Text] [Related]  

  • 22. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection.
    Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Bosco E; Mor V
    J Am Med Dir Assoc; 2021 Nov; 22(11):2228-2232. PubMed ID: 34534492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
    Klompas M
    JAMA; 2021 Nov; 326(20):2018-2020. PubMed ID: 34734985
    [No Abstract]   [Full Text] [Related]  

  • 25. Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls.
    Bitoun S; Henry J; Vauloup-Fellous C; Dib N; Belkhir R; Mouna L; Joly C; Desjardins D; Bitu M; Le Grand R; Seror R; Roque Afonso AM; Mariette X
    J Hematol Oncol; 2021 Oct; 14(1):166. PubMed ID: 34645504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi GL; Lippi G
    J Infect; 2021 Aug; 83(2):e4-e5. PubMed ID: 34214516
    [No Abstract]   [Full Text] [Related]  

  • 27. Temporal metabolic response and mRNA COVID-19 vaccination.
    Sookaromdee P; Wiwanitkit V
    Ann Nucl Med; 2021 Nov; 35(11):1270. PubMed ID: 34536212
    [No Abstract]   [Full Text] [Related]  

  • 28. [Development of thrombocytopenic purpura following BNT162b2 mRNA COVID-19 vaccination].
    Shibata K; Tanaka H; Otani A; Kubo M; Hasegawa A; Amano I
    Rinsho Ketsueki; 2021; 62(10):1519-1521. PubMed ID: 34732627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Lillie PJ; O'Brien P; Lawtie M; Jessop S; Easom NJW; Patmore R
    Clin Infect Dis; 2021 Nov; 73(10):1906-1908. PubMed ID: 33893480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination.
    Nishiguchi Y; Matsuyama H; Maeda K; Shindo A; Tomimoto H
    BMC Neurol; 2021 Nov; 21(1):452. PubMed ID: 34789193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.
    Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos C; Lucas C; Macario F; Haase M
    J Nephrol; 2021 Aug; 34(4):975-983. PubMed ID: 34050904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into Covid-19 disease. Apo-A1 antibodies are generated after mRNA Covid-19 vaccination and after Covid-19 infection.
    Twickler DTM
    Eur J Clin Invest; 2022 Feb; 52(2):e13729. PubMed ID: 34921724
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021.
    Mazagatos C; Monge S; Olmedo C; Vega L; Gallego P; Martín-Merino E; Sierra MJ; Limia A; Larrauri A; ;
    Euro Surveill; 2021 Jun; 26(24):. PubMed ID: 34142647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single Dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) Vaccine Is Associated With Lower Nasopharyngeal Viral Load Among Nursing Home Residents With Asymptomatic Coronavirus Disease 2019 (COVID-19).
    McEllistrem MC; Clancy CJ; Buehrle DJ; Lucas A; Decker BK
    Clin Infect Dis; 2021 Sep; 73(6):e1365-e1367. PubMed ID: 33768222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Not Available].
    Klimek L; Chaker AM; Cuevas M
    Laryngorhinootologie; 2021 May; 100(5):344-354. PubMed ID: 33684947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination.
    Mungmunpuntipantip R; Wiwanitkit V
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Jan; 40(1):48. PubMed ID: 34991852
    [No Abstract]   [Full Text] [Related]  

  • 38. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1498-1500. PubMed ID: 33887315
    [No Abstract]   [Full Text] [Related]  

  • 39. Note for "Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination".
    Rodríguez-Martín M
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Jan; 40(1):49. PubMed ID: 34920987
    [No Abstract]   [Full Text] [Related]  

  • 40. Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents.
    Long SS
    J Pediatr; 2021 Nov; 238():5. PubMed ID: 34332972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.